FDA
approval
· 2021-03-04
FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (FH2 Pharma LLC)
Summary
FDA approved FH2 Pharma LLC's supplemental application for OXYCODONE AND ACETAMINOPHEN tablets, enabling its marketing as a generic product under ANDA 040608.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OXYCODONE AND ACETAMINOPHEN (OXYCODONE AND ACETAMINOPHEN)